Table 1.

Summary characteristics of studies included in meta-analysis.

Study number	References	Country	Continent	TB burden*	Study design	Samples	TP/non-TP patients recruited	Test results
								True positive	False positive	False negative	True negative
1	(32)	Korea	Asia	Intermediate	Prospective	Peritoneal fluid	6/5	5	0	1	5
2	(26)	Korea	Asia	Intermediate	Prospective	Peripheral blood	29/21	25	7	4	14
						Peritoneal fluid	12/14	11	2	1	12
3	(33)	China	Asia	High	Retrospective	Peripheral blood	37/25	36	2	1	23
4	(34)	China	Asia	High	Prospective	Peripheral blood	24/17	22	4	2	13
5	(35)	China	Asia	High	Retrospective	Peritoneal fluid	40/38	36	3	2	35
6	(36)	China	Asia	High	Retrospective	Peritoneal fluid	28/30	26	4	2	26
7	(37)	China	Asia	High	Prospective	Peritoneal fluid	18/32	17	3	4	28
8	(38)	China	Asia	High	Retrospective	Peripheral blood	55/30	54	2	1	28
9	(27)	Korea	Asia	Intermediate	Prospective	Peripheral blood	45/29	38	12	7	17
						Peritoneal fluid	45/29	39	4	6	25
10	(39)	China	Asia	High	Retrospective	Peripheral blood	68/66	62	8	6	58
11	(28)	China	Asia	High	Retrospective	Peripheral blood	21/111	16	22	5	89
						Peritoneal fluid	21/105	20	40	1	65
12	(40)	China	Asia	High	Prospective	Peripheral blood	73/135	69	40	4	95

^*Refer to Global Tuberculosis Report 2019; TB, tuberculosis; TP, tuberculous peritonitis.